Fourth quarter revenue increased 9%, with full-year growth at 10%. Adjusted EBITDA net of NCI -- Rose 10% in the fourth ...

Consolidated Gross Merchandise Sales (GMS) -- $2.8 billion, down 4.8% year over year as reported; excluding Reverb, GMS was ...

Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores the urgent need to scale up newborn and early childhood screening, ...